Why the study?
Does acetorphan increase endogenous atrial natriuretic factor (ANF) levels and induce diuresis and natriuresis in healthy humans?
Population
Mice and 8 healthy human volunteers
Comparison
Acetorphan (oral administration in humans) vs Placebo
Design
RCT, Randomized, Double-blind, placebo-controlled
Authors
Loading...
Supports neprilysin inhibition to augment ANF effects; extends proof-of-concept from healthy volunteers toward heart failure trials.
Does acetorphan increase endogenous atrial natriuretic factor (ANF) levels and induce diuresis and natriuresis in healthy humans?
Inhibition of enkephalinase by acetorphan prevents the degradation of atrial natriuretic factor, leading to increased circulating levels, diuresis, and natriuresis, providing early proof-of-concept for neprilysin inhibition in cardiovascular disease.
Gros et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: